Digital Tools to Expand COVID-19 Testing in Exposed Individuals in Cameroon
NCT05684887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 433
Last updated 2023-12-18
Summary
According to the WHO, contact tracing - along with robust testing, isolation, and care of cases is a key strategy for interrupting chains of transmission of SARS-CoV-2 and reducing mortality associated with COVID-19. Contact tracing, however, has a number of challenges. These include incomplete identification of contacts, inefficiencies in paper-based reporting systems, complex data management requirements, and delays in the identification of contacts and testing of contacts. In many settings, contact tracing has proven to be too resource-intensive to implement at scale, especially with higher levels of community transmission, highlighting the need for more efficient contact tracing approaches. Digital tools afford the possibility of strengthening contact tracing for COVID-19, in a more efficient way. However, there is limited evidence of the effectiveness and impact of these tools in the COVID-19 response, including contact tracing.
This study proposes to compare the cascade of care between two strategies for COVID-19 contact tracing of SARS-CoV-2 infected index patients in Cameroon. In one strategy (intervention), the health facilities and health district testing units will implement contact tracing using a digital tool developed to support the tracing and testing of contacts (addition of a digital contact tracing module to the main platform for COVID-19 testing in Cameroon (Mamal Pro app)). This strategy will be compared to the standard contact tracing process (control), based on the current routine approach (use of the Mamal Pro application without the digital contact tracing module).
Conditions
Interventions
- OTHER
-
Digital based contact tracing
* Listing of contacts by SARS-CoV-2 positive individuals in Mamal Pro app + verification and validation by a health care worker. * Immediate access to the contact list in Mamal Pro once validated by the health care worker. * Contacts are immediately notified by text message automatically sent to all contacts with phone numbers and later called by the HCWs responsible for carrying out the contact tracing at the district level. * Contacts will be invited to go to the nearest testing facilities/units to get tested. * Those who are unable or refuse to come for testing are followed up by phone for 10 days for the occurrence of COVID-19 symptoms. * Information about the contact tracing process during communication with contacts are recorded in Mamal Pro digital contact tracing module.
Sponsors & Collaborators
-
Find
collaborator OTHER -
Cameroon Ministry of Public Health
collaborator UNKNOWN -
Elizabeth Glaser Pediatric AIDS Foundation
lead OTHER
Principal Investigators
-
Boris Tchakounte Youngui, MD, MPH · Elizabeth Glaser Pediatric AIDS Foundation
-
Godfrey Woelk, PhD, MCOMMH · Elizabeth Glaser Pediatric AIDS Foundation
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-10-18
- Primary Completion
- 2023-03-31
- Completion
- 2023-07-30
Countries
- Cameroon
Study Locations
More Related Trials
-
Effectiveness of Rapid Antigen Testing of Students for COVID-19 in Reducing Absences From Schools in Bangladesh
NCT05668078 ·Status: COMPLETED ·Phase: NA
-
An Epidemiological Surveillance Study to Determine the Incidence of ETEC in Children and Infants in Lusaka
NCT04838587 ·Status: COMPLETED
-
Enhancing the A in SAFE for Trachoma
NCT05634759 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children
NCT02165813 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Optimizing the Management of Acute Diarrhoeal Disease
NCT02803827 ·Status: COMPLETED ·Phase: PHASE3
-
Novel Diagnostics and Probiotics to Improve Management of Paediatric Acute Gastroenteritis
NCT02025452 ·Status: COMPLETED ·Phase: PHASE4
-
Contagious Misinformation Trial
NCT04112680 ·Status: COMPLETED ·Phase: NA
-
Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults
NCT03910972 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Azithromycin for Child Survival in Niger II
NCT06358872 ·Status: RECRUITING ·Phase: PHASE4
-
A Pilot Study Examining for the Presence of Fecal Coliforms and Tropical Diseases in Peru
NCT03078894 ·Status: UNKNOWN
-
Admission Pattern Among Children With Gastro-intestinal Infections Before and During the Covid-19 Pandemic
NCT06211621 ·Status: COMPLETED
-
Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea
NCT01955252 ·Status: COMPLETED ·Phase: PHASE3
-
Methylation, mIcrobiome, NUtritional sTatus, and dEvelopment of Stunted Children
NCT05779904 ·Status: ACTIVE_NOT_RECRUITING
-
A Baseline Study in Support of Clinical Evaluation of an Oral Shigella Vaccine Development in Africa
NCT04312906 ·Status: COMPLETED
-
Early Life Interventions for Childhood Growth and Development In Tanzania
NCT03268902 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment of Pediculosis (Head Lice) in Senegal
NCT03578679 ·Status: COMPLETED ·Phase: NA
-
Improving Care Through Azithromycin Research for Infants in Africa
NCT04235816 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Post Discharge Trial to Enhance Immunity in Severely Malnourished Children
NCT06530485 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Digital Payment to Campaign Health Workers on Vaccination Coverage
NCT05684081 ·Status: UNKNOWN ·Phase: NA
-
Rheumatic Heart Disease Community Streptococcal Treatment Program "RESET"
NCT05276999 ·Status: COMPLETED ·Phase: NA
-
Use of Airtime Structure to Improve Interactive Voice Response Surveys in Bangladesh and Uganda
NCT03773146 ·Status: COMPLETED ·Phase: NA
-
Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation
NCT00130910 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Novel Antimicrobial Hand Towels
NCT02512614 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger
NCT00618449 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of a Multiple Behaviour Programme for Diarrhoea Management
NCT02081521 ·Status: COMPLETED ·Phase: NA